MedPath

Remimazolam

Generic Name
Remimazolam
Brand Names
Byfavo
Drug Type
Small Molecule
Chemical Formula
C21H19BrN4O2
CAS Number
308242-62-8
Unique Ingredient Identifier
7V4A8U16MB
Background

Remimazolam is an ultra short-acting benzodiazepine used in the induction and maintenance of sedation during short (<30 minute) procedures. Recent trends in anesthesia-related drug development have touted the benefits of so-called "soft drugs" - these agents, such as remifentanil, are designed to be metabolically fragile and thus susceptible to rapid biotransformation and elimination as inactive metabolites. These "soft drugs" are useful in the context of surgical procedures, wherein a rapid onset/offset is desirable, enabling anesthesiologists to manipulate drug concentrations as needed. Remimazolam was the first "soft" benzodiazepine analog to be developed and was approved for use by the FDA in July 2020 under the brand name Byfavo.

Indication

Remimazolam is indicated for the induction and maintenance of procedural sedation in adults undergoing procedures lasting 30 minutes or less.

Associated Conditions
Procedural Sedation

Effective Dose of Remimazolam for Sedation in Patients Undergoing Lower Extremity Surgery Under Spinal Anesthesia

Phase 4
Completed
Conditions
Sedatives
Remimazolam
Orthopedic Procedures
Anesthesia, Spinal
Interventions
First Posted Date
2022-05-18
Last Posted Date
2022-12-19
Lead Sponsor
Asan Medical Center
Target Recruit Count
51
Registration Number
NCT05379777
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Remimazolam Versus Propopol Based Total Intravenous Anesthesia for Breast Surgery

Not Applicable
Withdrawn
Conditions
Hypotension
Interventions
First Posted Date
2022-05-17
Last Posted Date
2024-11-28
Lead Sponsor
Seoul National University Hospital
Registration Number
NCT05375747
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

The Application of Remazolam in Gastroenteroscopy

Not Applicable
Completed
Conditions
Gastroenterology
Interventions
First Posted Date
2022-05-02
Last Posted Date
2025-02-19
Lead Sponsor
Yangzhou University
Target Recruit Count
83
Registration Number
NCT05357430
Locations
🇨🇳

Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu, China

Quality of Recovery of Remimazolam Versus Sevoflurane in Transurethral Bladder Resection.

Not Applicable
Completed
Conditions
Quality of Recovery
Interventions
First Posted Date
2022-05-02
Last Posted Date
2023-03-09
Lead Sponsor
Kangbuk Samsung Hospital
Target Recruit Count
36
Registration Number
NCT05356091
Locations
🇰🇷

Eunah Cho, Seoul, Korea, Republic of

Remimazolam in the Extraction of Impacted Wisdom Teeth

Not Applicable
Conditions
Dental Anxiety
Sedation Complication
Anterograde Amnesia
Interventions
First Posted Date
2022-04-27
Last Posted Date
2023-04-07
Lead Sponsor
Peking Union Medical College Hospital
Target Recruit Count
150
Registration Number
NCT05350085
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

ED90 of Remimazolam Loading Dose for Sedation in Patients Under Monitored Anesthetic Care

Phase 4
Completed
Conditions
Remimazolam
Orthopedic Procedures
Sedatives
Interventions
First Posted Date
2022-04-22
Last Posted Date
2022-07-21
Lead Sponsor
Asan Medical Center
Target Recruit Count
50
Registration Number
NCT05340335
Locations
🇰🇷

Asan Medical Center, Seoul, Korea, Republic of

Remimazolam Total Intravenous Anesthesia Under Analgesia Nociception Index-guidance

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Total Knee Arthroplasty
Remimazolam
Interventions
First Posted Date
2022-04-12
Last Posted Date
2023-07-19
Lead Sponsor
Gangnam Severance Hospital
Target Recruit Count
84
Registration Number
NCT05322902
Locations
🇰🇷

Gangnam Severance Hospital, Seoul, Korea, Republic of

Effects of Remimazolam on Quality of Recovery After Ambulatory Surgery

Completed
Conditions
Quality of Recovery
Day Surgery
Patient Outcome Assessment
Remimazolam
First Posted Date
2022-04-11
Last Posted Date
2022-04-11
Lead Sponsor
Seoul National University Bundang Hospital
Target Recruit Count
38
Registration Number
NCT05320016
Locations
🇰🇷

Seoul National University Bundang Hospital, Seongnam-si, Gyunggi-do, Korea, Republic of

Sedation With Remimazolam During Spinal Anesthesia

Not Applicable
Completed
Conditions
Sedation
Spinal Anesthesia
Interventions
First Posted Date
2022-03-31
Last Posted Date
2023-05-12
Lead Sponsor
Gangnam Severance Hospital
Target Recruit Count
62
Registration Number
NCT05305248
Locations
🇰🇷

Gangnam Severance Hospital, Seoul, Korea, Republic of

Dose Finding Study of Remimazolam for Laryngeal Mask Airway Insertion

Not Applicable
Conditions
Orthopedic Surgery
Interventions
First Posted Date
2022-03-28
Last Posted Date
2022-03-28
Lead Sponsor
Yonsei University
Target Recruit Count
25
Registration Number
NCT05298228
Locations
🇰🇷

Yonsei University Health System, Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath